Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

Study finds vaccines cut severe variant COVID disease after one shot
Pharmaforum
Fri, 07/23/21 - 11:13 am
Tags:
real world evidence, COVID-19, vaccines, Pfizer, BioNTech, Moderna, AstraZeneca, Delta COVID-19 variant
Two doses of Pfizer, AstraZeneca shots effective against Delta variant: study
Reuters
Wed, 07/21/21 - 09:09 pm
Tags:
Pfizer, AstraZeneca, vaccines, COVID-19, Delta COVID-19 variant
AstraZeneca heralds new chapter as Alexion acquisition completed
Biopharma Reporter
Wed, 07/21/21 - 08:46 pm
Tags:
AstraZeneca, Alexion, M&A
Alexion's new blockbuster Ultomiris keeps gaining steam as $39B AstraZeneca deal looms
Fierce Pharma
Wed, 07/21/21 - 12:01 am
Tags:
AstraZeneca, Alexion, Ultomiris
AstraZeneca earns another approval in jam-packed Chinese PD-(L)1 market, this time in late-stage lung cancer
Endpoints
Mon, 07/19/21 - 11:05 am
Tags:
AstraZeneca, China, Imfinzi
Alexion touts new PhIII data of Soliris successor as planned AstraZeneca takeover looms
Endpoints
Fri, 07/16/21 - 10:40 am
Tags:
Alexion, AstraZeneca, M&A, clinical trials, Ultomiris, myasthenia gravis
Novartis may have the most new drug approvals, but Roche, Lilly and AbbVie's launches win on value: report
Fierce Pharma
Thu, 07/15/21 - 12:39 pm
Tags:
Novartis, AbbVie, GSK, Roche, Eli Lilly, AstraZeneca, FDA, drug launches, drug approvals
AZ, J&J tweaking COVID shots to reduce clotting risks; report
Pharmaforum
Wed, 07/14/21 - 10:38 am
Tags:
AstraZeneca, JNJ, COVID-19, vaccines, blood clots
AstraZeneca's planned takeover of Alexion clears last regulatory review, deal to close next week
Endpoints
Wed, 07/14/21 - 10:17 am
Tags:
AstraZeneca, Alexion, M&A
Study highlights need for full Covid vaccination to protect against Delta variant
Stat
Thu, 07/8/21 - 11:53 pm
Tags:
vaccines, COVID-19, Delta COVID-19 variant, AstraZeneca, Pfizer, BioNTech
Big pharma leads the way in stock market resurgence
EP Vantage
Wed, 07/7/21 - 10:49 am
Tags:
Big Pharma, pharma stocks, Acadia Pharmaceuticals, AstraZeneca, Biogen, Eli Lilly, GSK, Merck, Moderna Therapeutics, Novartis, Sanofi, Provention Bio
AstraZeneca clears latest hurdle for Alexion acquisition after EU clearance
PM Live
Tue, 07/6/21 - 10:59 am
Tags:
AstraZeneca, Alexion, M&A, Europe
AZ drug for hard-to-treat heart failure has mixed results in trial
Pharmaforum
Fri, 07/2/21 - 10:59 am
Tags:
AstraZeneca, heart failure, clinical trials, AZD4831
Key third-quarter readouts for big pharma
EP Vantage
Tue, 06/29/21 - 10:59 am
Tags:
clinical trials, Pfizer, Roche, idanacogene elaparvovec, Alexion, AstraZeneca, Ultomiris, AbbVie, Rinvoq, Novartis, sabatolimab
Mixing brands of COVID-19 vaccines offers strong protection against virus, study suggests
Beckers Hospital Review
Mon, 06/28/21 - 06:50 pm
Tags:
vaccines, COVID-19, Pfizer, AstraZeneca
Sanofi, AstraZeneca mark big leap toward filing of RSV drug in 2022, with safety data in hand to challenge Synagis
Endpoints
Mon, 06/28/21 - 10:58 am
Tags:
Sanofi, AstraZeneca, RSV, clinical trials, nirsevimab, Synagis
AstraZeneca kick-starts new COVID variant-busting vaccine test
Fierce Biotech
Mon, 06/28/21 - 10:55 am
Tags:
AstraZeneca, COVID-19, vaccines, AZD2816, COVID-19 variants
AZ starts phase 2/3 trial of new-variant COVID-19 vaccine
Pharmaforum
Sun, 06/27/21 - 10:52 pm
Tags:
AstraZeneca, clinical trials, vaccines, COVID-19
ADA 2021: AstraZeneca touts Bydureon trial win in children and adolescents with type 2 diabetes
Fierce Pharma
Fri, 06/25/21 - 12:16 pm
Tags:
AstraZeneca, Bydureon, diabetes, pediatric, type 2 diabetes, clinical trials
Pfizer and AZ Prove Their COVID-19 Vaccines Can Keep Up with Delta and Kappa Variants
BioSpace
Thu, 06/24/21 - 11:39 pm
Tags:
Pfizer, AstraZeneca, COVID-19, COVID-19 variants, vaccines

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.